EXOSENS SAS (EXENS.PA) Stock Fundamental Analysis
Europe - EPA:EXENS - FR001400Q9V2 - Common Stock
42.4 EUR
-2.5 (-5.57%)
We assign a fundamental rating of 5 out of 10 to EXENS. EXENS was compared to 44 industry peers in the Aerospace & Defense industry. EXENS is in great health and has no worries on liquidiy or solvency at all, but the profibility rating is only average. EXENS is valued quite expensive, but it does show an excellent growth.
1. Profitability
1.1 Basic Checks
In the past year EXENS was profitable.
EXENS had a positive operating cash flow in the past year.
1.2 Ratios
The Return On Assets of EXENS (3.54%) is comparable to the rest of the industry.
EXENS's Return On Equity of 7.14% is on the low side compared to the rest of the industry. EXENS is outperformed by 61.36% of its industry peers.
EXENS has a Return On Invested Capital (7.97%) which is comparable to the rest of the industry.
Measured over the past 3 years, the Average Return On Invested Capital for EXENS is below the industry average of 9.16%.
The last Return On Invested Capital (7.97%) for EXENS is above the 3 year average (7.01%), which is a sign of increasing profitability.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 3.54% | ||
| ROE | 7.14% | ||
| ROIC | 7.97% |
ROA(3y)2.89%
ROA(5y)N/A
ROE(3y)7.53%
ROE(5y)N/A
ROIC(3y)7.01%
ROIC(5y)N/A
1.3 Margins
EXENS's Profit Margin of 7.79% is fine compared to the rest of the industry. EXENS outperforms 77.27% of its industry peers.
Looking at the Operating Margin, with a value of 18.28%, EXENS belongs to the top of the industry, outperforming 97.73% of the companies in the same industry.
EXENS has a Gross Margin of 73.86%. This is amongst the best in the industry. EXENS outperforms 93.18% of its industry peers.
EXENS's Gross Margin has been stable in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 18.28% | ||
| PM (TTM) | 7.79% | ||
| GM | 73.86% |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.14%
GM growth 5YN/A
2. Health
2.1 Basic Checks
With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), EXENS is destroying value.
The number of shares outstanding for EXENS has been reduced compared to 1 year ago.
Compared to 1 year ago, EXENS has an improved debt to assets ratio.
2.2 Solvency
EXENS has an Altman-Z score of 4.22. This indicates that EXENS is financially healthy and has little risk of bankruptcy at the moment.
Looking at the Altman-Z score, with a value of 4.22, EXENS belongs to the top of the industry, outperforming 84.09% of the companies in the same industry.
EXENS has a debt to FCF ratio of 4.69. This is a neutral value as EXENS would need 4.69 years to pay back of all of its debts.
EXENS's Debt to FCF ratio of 4.69 is fine compared to the rest of the industry. EXENS outperforms 63.64% of its industry peers.
A Debt/Equity ratio of 0.61 indicates that EXENS is somewhat dependend on debt financing.
EXENS has a Debt to Equity ratio of 0.61. This is in the lower half of the industry: EXENS underperforms 61.36% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.61 | ||
| Debt/FCF | 4.69 | ||
| Altman-Z | 4.22 |
ROIC/WACC0.99
WACC8.02%
2.3 Liquidity
EXENS has a Current Ratio of 2.51. This indicates that EXENS is financially healthy and has no problem in meeting its short term obligations.
With an excellent Current ratio value of 2.51, EXENS belongs to the best of the industry, outperforming 88.64% of the companies in the same industry.
A Quick Ratio of 1.67 indicates that EXENS should not have too much problems paying its short term obligations.
EXENS's Quick ratio of 1.67 is amongst the best of the industry. EXENS outperforms 86.36% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 2.51 | ||
| Quick Ratio | 1.67 |
3. Growth
3.1 Past
The Earnings Per Share has grown by an impressive 102.95% over the past year.
EXENS shows a strong growth in Revenue. In the last year, the Revenue has grown by 35.04%.
The Revenue has been growing by 33.36% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)102.95%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%875.18%
Revenue 1Y (TTM)35.04%
Revenue growth 3Y33.36%
Revenue growth 5YN/A
Sales Q2Q%20.13%
3.2 Future
EXENS is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 25.39% yearly.
The Revenue is expected to grow by 13.99% on average over the next years. This is quite good.
EPS Next Y55.51%
EPS Next 2Y37.62%
EPS Next 3Y30.01%
EPS Next 5Y25.39%
Revenue Next Year19.25%
Revenue Next 2Y16.41%
Revenue Next 3Y14.66%
Revenue Next 5Y13.99%
3.3 Evolution
The estimated forward Revenue growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
4. Valuation
4.1 Price/Earnings Ratio
A Price/Earnings ratio of 57.30 indicates a quite expensive valuation of EXENS.
EXENS's Price/Earnings ratio is a bit more expensive when compared to the industry. EXENS is more expensive than 61.36% of the companies in the same industry.
EXENS is valuated expensively when we compare the Price/Earnings ratio to 25.07, which is the current average of the S&P500 Index.
Based on the Price/Forward Earnings ratio of 22.60, the valuation of EXENS can be described as rather expensive.
Based on the Price/Forward Earnings ratio, EXENS is valued a bit cheaper than 65.91% of the companies in the same industry.
When comparing the Price/Forward Earnings ratio of EXENS to the average of the S&P500 Index (34.08), we can say EXENS is valued slightly cheaper.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 57.3 | ||
| Fwd PE | 22.6 |
4.2 Price Multiples
EXENS's Enterprise Value to EBITDA ratio is in line with the industry average.
EXENS's Price/Free Cash Flow is on the same level as the industry average.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 37.71 | ||
| EV/EBITDA | 21.61 |
4.3 Compensation for Growth
EXENS's PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
A more expensive valuation may be justified as EXENS's earnings are expected to grow with 30.01% in the coming years.
PEG (NY)1.03
PEG (5Y)N/A
EPS Next 2Y37.62%
EPS Next 3Y30.01%
5. Dividend
5.1 Amount
EXENS has a yearly dividend return of 0.22%, which is pretty low.
EXENS's Dividend Yield is slightly below the industry average, which is at 1.19.
With a Dividend Yield of 0.22, EXENS pays less dividend than the S&P500 average, which is at 2.44.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0.22% |
5.2 History
Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years0
5.3 Sustainability
DPN/A
EPS Next 2Y37.62%
EPS Next 3Y30.01%
EPA:EXENS (11/21/2025, 5:27:57 PM)
42.4
-2.5 (-5.57%)
Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryAerospace & Defense
Earnings (Last)
Earnings (Next)
Inst Owners43.61%
Inst Owner ChangeN/A
Ins Owners1.86%
Ins Owner ChangeN/A
Market Cap2.15B
Revenue(TTM)394.08M
Net Income(TTM)30.68M
Analysts77.78
Price Target48.28 (13.87%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0.22% |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)8.1%
PT rev (3m)18.33%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)-1.38%
EPS NY rev (3m)-2.31%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)-0.18%
Revenue NY rev (3m)0.36%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 57.3 | ||
| Fwd PE | 22.6 | ||
| P/S | 5.46 | ||
| P/FCF | 37.71 | ||
| P/OCF | 21.29 | ||
| P/B | 5.01 | ||
| P/tB | N/A | ||
| EV/EBITDA | 21.61 |
EPS(TTM)0.74
EY1.75%
EPS(NY)1.88
Fwd EY4.42%
FCF(TTM)1.12
FCFY2.65%
OCF(TTM)1.99
OCFY4.7%
SpS7.76
BVpS8.46
TBVpS-0.02
PEG (NY)1.03
PEG (5Y)N/A
Graham Number11.87
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 3.54% | ||
| ROE | 7.14% | ||
| ROCE | 9.7% | ||
| ROIC | 7.97% | ||
| ROICexc | 9.07% | ||
| ROICexgc | 26.62% | ||
| OM | 18.28% | ||
| PM (TTM) | 7.79% | ||
| GM | 73.86% | ||
| FCFM | 14.49% |
ROA(3y)2.89%
ROA(5y)N/A
ROE(3y)7.53%
ROE(5y)N/A
ROIC(3y)7.01%
ROIC(5y)N/A
ROICexc(3y)7.64%
ROICexc(5y)N/A
ROICexgc(3y)25.3%
ROICexgc(5y)N/A
ROCE(3y)8.53%
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.14%
GM growth 5YN/A
F-Score6
Asset Turnover0.45
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.61 | ||
| Debt/FCF | 4.69 | ||
| Debt/EBITDA | 2.32 | ||
| Cap/Depr | 105.56% | ||
| Cap/Sales | 11.17% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 88.9% | ||
| Profit Quality | 186.1% | ||
| Current Ratio | 2.51 | ||
| Quick Ratio | 1.67 | ||
| Altman-Z | 4.22 |
F-Score6
WACC8.02%
ROIC/WACC0.99
Cap/Depr(3y)105.99%
Cap/Depr(5y)N/A
Cap/Sales(3y)10.64%
Cap/Sales(5y)N/A
Profit Quality(3y)171.48%
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)102.95%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%875.18%
EPS Next Y55.51%
EPS Next 2Y37.62%
EPS Next 3Y30.01%
EPS Next 5Y25.39%
Revenue 1Y (TTM)35.04%
Revenue growth 3Y33.36%
Revenue growth 5YN/A
Sales Q2Q%20.13%
Revenue Next Year19.25%
Revenue Next 2Y16.41%
Revenue Next 3Y14.66%
Revenue Next 5Y13.99%
EBIT growth 1Y45.26%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year77.63%
EBIT Next 3Y31.34%
EBIT Next 5Y25.17%
FCF growth 1Y181.68%
FCF growth 3Y33.59%
FCF growth 5YN/A
OCF growth 1Y90.75%
OCF growth 3Y31.16%
OCF growth 5YN/A
EXOSENS SAS / EXENS.PA FAQ
What is the fundamental rating for EXENS stock?
ChartMill assigns a fundamental rating of 5 / 10 to EXENS.PA.
What is the valuation status of EXOSENS SAS (EXENS.PA) stock?
ChartMill assigns a valuation rating of 3 / 10 to EXOSENS SAS (EXENS.PA). This can be considered as Overvalued.
Can you provide the profitability details for EXOSENS SAS?
EXOSENS SAS (EXENS.PA) has a profitability rating of 4 / 10.
What are the PE and PB ratios of EXOSENS SAS (EXENS.PA) stock?
The Price/Earnings (PE) ratio for EXOSENS SAS (EXENS.PA) is 57.3 and the Price/Book (PB) ratio is 5.01.
What is the financial health of EXOSENS SAS (EXENS.PA) stock?
The financial health rating of EXOSENS SAS (EXENS.PA) is 7 / 10.